Search Results - "Campos Tapias, I"
-
1
Real World Treatment Patterns of PCSK9 Inhibitors Among Patients with Dyslipidemia in Germany, Spain, and United Kingdom
Published in Value in health (01-10-2017)“…OBJECTIVES: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i), evolocumab and alirocumab, were recently approved as adjuncts to maximal…”
Get full text
Journal Article -
2
A retrospective chart review study describing metastatic melanoma patients profile and treatment patterns in Spain
Published in Clinical & translational oncology (01-12-2019)“…Purpose To describe patient characteristics by disease stage, resectability status and current treatment management after first diagnosis of IIIB to IV1c…”
Get full text
Journal Article -
3
Resource utilization and costs associated with achieved LDL-C levels in patients following a myocardial infarction treated with lipid-lowering therapies in Spain
Published in European heart journal (01-11-2020)“…Abstract Background/Introduction Reduction in low-density lipoprotein cholesterol (LDL-C) significantly reduces cardiovascular (CV) risk, especially in…”
Get full text
Journal Article -
4
PCV146 - Real World Treatment Patterns of PCSK9 Inhibitors Among Patients with Dyslipidemia in Germany, Spain, and United Kingdom
Published in Value in health (01-10-2017)Get full text
Journal Article -
5
PCV61 - PRODUCTIVITY LOSS AND LOCAL INDIRECT COSTS ASSOCIATED WITH ACUTE CORONARY SYNDROME AND STROKE IN SPAIN
Published in Value in health (01-10-2018)Get full text
Journal Article -
6
Treatment Patterns of Metastatic Melanoma in Five European Countries
Published in Value in health (01-05-2016)Get full text
Journal Article -
7
PCN214 - Treatment Patterns of Metastatic Melanoma in Five European Countries
Published in Value in health (01-05-2016)Get full text
Journal Article -
8
PCN298 - The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland: a Comparison Between the use of Denosumab and Zoledronic Acid In Patients with Prostate Cancer And Bone Metastases
Published in Value in health (01-11-2015)Get full text
Journal Article -
9
PCN299 - The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland: A Comparison Between the use of Denosumab and Zoledronic acid in Patients With Breast Cancer and Bone Metastases
Published in Value in health (01-11-2015)Get full text
Journal Article -
10
The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland: A Comparison Between the use of Denosumab and Zoledronic acid in Patients With Breast Cancer and Bone Metastases
Published in Value in health (01-11-2015)Get full text
Journal Article -
11
The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland: a Comparison Between the use of Denosumab and Zoledronic Acid In Patients with Prostate Cancer And Bone Metastases
Published in Value in health (01-11-2015)Get full text
Journal Article